Sunshine Biopharma (SBFM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,976 | -1,778 | -1,284 | -4,506 | -3,256 |
| Depreciation Amortization | 158 | 94 | 43 | 149 | 107 |
| Accounts receivable | -1,321 | -2,308 | -536 | -594 | -119 |
| Accounts payable and accrued liabilities | N/A | 2,795 | 1,293 | N/A | N/A |
| Other Working Capital | -6,314 | -6,090 | -1,956 | -4,418 | -2,936 |
| Other Operating Activity | 1,333 | -475 | -745 | 594 | 118 |
| Operating Cash Flow | $-9,120 | $-7,763 | $-3,185 | $-8,775 | $-6,085 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,555 | -1,038 | -63 | -82 | -465 |
| Purchase Sale Intangibles | -327 | -235 | -637 | -706 | -20 |
| Other Investing Activity | -327 | -173 | -606 | -574 | 78 |
| Investing Cash Flow | $-1,882 | $-1,211 | $-669 | $-656 | $-387 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 10,463 | 8,567 | 8,567 | 4,093 | 4,090 |
| Common Stock Repurchased | -3,140 | -3,140 | -3,140 | -541 | -541 |
| Other Financing Activity | 0 | -58 | -30 | -126 | -93 |
| Financing Cash Flow | $7,323 | $5,370 | $5,398 | $3,426 | $3,456 |
| Exchange Rate Effect | -408 | -1,180 | -402 | 472 | 36 |
| Beginning Cash Position | 16,292 | 16,292 | 16,292 | 21,826 | 21,826 |
| End Cash Position | 12,207 | 11,508 | 17,434 | 16,292 | 18,846 |
| Net Cash Flow | $-4,086 | $-4,785 | $1,142 | $-5,534 | $-2,980 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,120 | -7,763 | -3,185 | -8,775 | -6,085 |
| Capital Expenditure | -1,555 | -1,038 | -63 | -82 | -465 |
| Free Cash Flow | -10,674 | -8,800 | -3,248 | -8,857 | -6,550 |